会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Cosmetic or pharmaceutical preparations which comprise enaminotriazines as light protection agents, and novel enaminotriazines
    • 包含氨基三嗪作为防晒剂的化妆品或药物制剂,以及新的氨基三嗪
    • US07217820B2
    • 2007-05-15
    • US10984241
    • 2004-11-10
    • Thomas HeidenfelderKristin TiefenseeThomas Wünsch
    • Thomas HeidenfelderKristin TiefenseeThomas Wünsch
    • C07D251/70A61K7/42
    • A61Q17/04A61K8/4966C07D251/70
    • The invention relates to the use of enaminotriazines of the formula I in which the radicals Y, independently of one another, are hydrogen, an optionally substituted aliphatic, cycloaliphatic, araliphatic or aromatic radical having in each case up to 18 carbon atoms, the radicals X are identical or different, where at least one of the radicals X is the ethenyl radical of the formula II and X may also have the meanings of Y, and where in the formula II the radicals R are identical or different and are cyano, optionally esterified carboxyl, substituted carbonyl, optionally substituted aminocarbonyl, optionally esterified sulfo, substituted sulfonyl or optionally esterified phosphono, and where two adjacent radicals R may optionally form a ring and the radicals R′ are identical or different and are hydrogen, an optionally substituted aliphatic, cycloaliphatic or aromatic radical having in each case up to 18 carbon atoms, as UV filters in cosmetic or pharmaceutical preparations for protecting human skin or human hair against solar rays, alone or together with compounds which absorb in the UV region and which are known per se for cosmetic preparations.
    • 本发明涉及式I的氨基三嗪的用途,其中基团Y彼此独立地为氢,任选取代的脂族,脂环族,芳脂族或芳族基团,其中每种情况最多可达18个碳原子,基团X 相同或不同,其中基团X中的至少一个是式II的乙烯基,X也可以具有Y的含义,并且其中在式II中,基团R相同或不同并且是氰基,任选地被酯化 羧基,取代的羰基,任选取代的氨基羰基,任选酯化的磺基,取代的磺酰基或任选酯化的膦酰基,并且其中两个相邻的基团R可以任选地形成环,并且基团R'相同或不同,并且是氢,任选取代的脂族,脂环族 或在每种情况下最多18个碳原子的芳族基团,作为化妆品中的UV过滤剂或用于保护的药物制剂 人类皮肤或人类头发抵抗太阳光线,单独或与在UV区域吸收的化合物一起,并且本身已知本身用于化妆品制剂。
    • 8. 发明授权
    • Emulsion graft polymer
    • 乳液接枝聚合物
    • US5767201A
    • 1998-06-16
    • US849893
    • 1997-06-16
    • Guenter ZimmerJosef PoegelKristin Tiefensee
    • Guenter ZimmerJosef PoegelKristin Tiefensee
    • C08F285/00C08L33/12C08L51/00
    • C08L51/00C08F285/00C08L33/12C08L51/003
    • Emulsion graft copolymers are composed of A) from 5 to 18% by weight of a first stage comprising a.sub.1) from 85 to 99% by weight of methyl methacrylate, a.sub.2) from 1 to 15% by weight of C.sub.1 -C.sub.8 -alkyl acrylate, a.sub.3) from 0 to 2% by weight of allyl methacrylate and a.sub.4) from 0 to 3% by weight of further di- or polyfunctional comonomers, B) from 25 to 35% by weight of a second stage comprising b.sub.1) from 10 to 25% by weight of vinylaromatic monomers, b.sub.2) from 75 to 90% by weight of C.sub.1 -C.sub.20 -alkyl acrylate and b.sub.3) from 0 to 3% by weight of allyl methacrylate, C) from 30 to 40% by weight of a third stage comprising c.sub.1) from 15 to 27% by weight of vinylaromatic monomers, c.sub.2) from 73 to 85% by weight of C.sub.1 -C.sub.20 -alkyl acrylate and c.sub.3) from 0 to 3% by weight of allyl methacrylate and D) from 15 to 30% by weight of a fourth stage comprising d.sub.1) from 85 to 96% by weight of methyl methacrylate, d.sub.2) from 3.8 to 10% by weight of C.sub.1 -C.sub.8 -alkyl acrylate, d.sub.3) from 0 to 2% by weight of further di- or polyfunctional comonomers and d.sub.4) from 0.2 to 3% by weight of a regulator, with the proviso that the ratio of the amounts of vinylaromatic monomers c.sub.1 :b.sub.1 is from 1.3:1 to 1.9:1 and the sum of the components A to D is 100% by weight.
    • PCT No.PCT / EP95 / 05056 Sec。 371日期:1997年6月16日 102(e)日期1997年6月16日PCT 1995年12月20日PCT PCT。 WO96 / 19509 PCT出版物 日期1996年6月27日乳液接枝共聚物由以下组成:A)5〜18重量%的第一阶段,其包含a1)85-99重量%甲基丙烯酸甲酯,a2)1〜15重量% C8烷基丙烯酸酯,a3)0-2重量%的甲基丙烯酸烯丙酯和a4)0-3重量%的另外的二官能或多官能共聚单体,B)25-35重量%的第二阶段,包括b1 )10至25重量%的乙烯基芳族单体,b2)75至90重量%的丙烯酸C 1 -C 20烷基酯和b 3)0至3重量%的甲基丙烯酸烯丙酯,C)30至40重量% 第三阶段的重量,其包含c1)15至27重量%的乙烯基芳族单体,c2)73至85重量%的丙烯酸C1-C20烷基酯和c3)0-3重量%甲基丙烯酸烯丙酯和D )15至30重量%的第四阶段,其包含d1)85至96重量%的甲基丙烯酸甲酯,d2)3.8至10重量%的丙烯酸C 1 -C 8烷基酯,d 3)0至2重量% 重量的另外的二 - 或 多官能共聚单体和d4)0.2-3重量%的调节剂,条件是乙烯基芳族单体c1:b1的量的比例为1.3:1至1.9:1,组分A至D的总和为 100重量%。